Veterinary Medicines

CALIERMUTIN (MACROMUTIN) 162 mg/ml SOLUTION FOR INJECTION FOR PIGS

Authorised
  • Tiamulin
Download as PDF

Product identification

Medicine name:
CALIERMUTIN (MACROMUTIN) 162 mg/ml SOLUTION FOR INJECTION FOR PIGS
Caliermutin 162 mg/ml solução injetável para suínos
Active substance:
  • Tiamulin
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Tiamulin
    162.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • Clear glass vials, quality type II (European Pharmacopoeia), of 100 ml, provided with grey brubber stoppers of bromobutyl, formulation PH 4001/45, and metallic aluminium coloured (silver) capsules with blue FLIP-OFF ring.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Calier Portugal Medicamentos E Produtos Veterinarios S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 227/01/09DFVPT
Date of authorisation status change:
Reference member state:
  • Portugal
Procedure number:
  • PT/V/102/001
Concerned member states:
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."